2CBCB-NBOMe

Source: Wikipedia, the free encyclopedia.
2CBCB-NBOMe
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
Identifiers
  • N-[(3-bromo-2,5-dimethoxy-bicyclo[4,2,0]octa-1,3,5-trien-7-yl)methyl]-1-(2-methoxyphenyl)methanamine
JSmol)
  • COc1ccccc1CNCC3c2c(C3)c(OC)c(Br)cc2OC
  • InChI=1S/C19H22BrNO3/c1-22-16-7-5-4-6-12(16)10-21-11-13-8-14-18(13)17(23-2)9-15(20)19(14)24-3/h4-7,9,13,21H,8,10-11H2,1-3H3/t13-/m0/s1 checkY
  • Key:CLSBQRBXTFTLEX-ZDUSSCGKSA-N checkY
 ☒NcheckY (what is this?)  (verify)

2CBCB-NBOMe (NBOMe-TCB-2) is a compound indirectly derived from the

NBOMe-2C-I and Bromo-DragonFLY.[1]

Analogues and derivatives

Legality

United Kingdom

This substance is a

Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[6]

United States

2CBCB-NBOMe is a controlled substance in Vermont as of January 2016.[7]

References

  1. ProQuest 304838368
    .
  2. ^ "Explore N-(2C-B)-Fentanyl | PiHKAL · info". isomerdesign.com.
  3. ^ "Explore N-(2C-FLY)-Fentanyl | PiHKAL · info". isomerdesign.com.
  4. PMID 15537358
    .
  5. ^ Beta-hydroxyphenylalkylamines and their use for treating glaucoma
  6. ^ "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.
  7. ^ "Regulated Drugs Rule" (PDF). Vermont Department of Health. Retrieved 14 October 2015.